SCULLY WILLIAM P purchased $857K of PRTA (indirect holdings)
SCULLY WILLIAM P purchased 100,000 indirectly-held shares of PROTHENA CORP PUBLIC LTD CO (PRTA) at $8.57 ($0.86M total) on 2026-10-02.
How this was made
The 30-second read
Why it matters
The filing provides the first public disclosure of the insider's purchase, offering a modest signal of confidence.
Market read
Insider buying is a low‑impact catalyst; traders may note it but unlikely to drive significant price movement.
What to watch
Potential upcoming clinical data or regulatory events not disclosed in the filing.
Background
SEC Form 4 filing reports insider transaction for Prothena Corp (PRTA).
Ticker impact
Form 4 disclosed a $857K open‑market purchase by a 10% owner, indicating insider confidence.
likely slight upward pressure as market prices in insider confidence
The purchase size is modest relative to market cap, but the buyer holds a significant stake, suggesting confidence.
Market effects
Minimal impact on biotech sector; insider activity is routine.
No significant regional effect.
Limited to investors tracking insider transactions.
Counterpoint
The purchase could be a routine portfolio rebalancing rather than a bullish signal.
Key entities
- companyProthena Corp Public Ltd Co
Biotech firm listed on Nasdaq under ticker PRTA.
- personScully William P
Insider holding 10% of Prothena, reported purchase of 100,000 shares.